STI Clinical Update Webinar – The Changing Face of STIs: Skin Manifestations Every Public Health Professional Should Know
September 11, 2026 12:00PM – 1:15PM (PDT)
Recording will be available soon.
Registration closes on September 10, 2026 at 3:00PM (PDT). Please note: CME not offered for viewing any available recording of the webinar.
Presenters
Kieron S. Leslie, MBBS, DTMH Medical Dermatologist University of California San Francisco (UCSF)
Course Description
Stay current on the changing face of STIs with an expert update on key dermatologic manifestations, including syphilis, mpox, Trichophyton mentagrophytes genotype VII, and emerging causes of facial folliculitis in men who have sex with men.
Learning Objectives
Recognize the skin manifestations of syphilis
Review the epidemiology and clinical features of mpox infection
Distinguish the rashes of T. Mentag VII
Appreciate Klebsiella aerobenes as an emerging pathogen causing facial folliculitis in men who have sex with men
STI Clinical Update Webinar – Mpox Clinical Update: What’s New, What to Suspect, What to Do – Recognition & Prevention
June 2, 2026 CME not available for viewing the webinar recording.
Stay current on mpox!
This clinician-focused webinar reviews the latest U.S. and global epidemiology of mpox, including clade I. Learn how and when to suspect, diagnose, manage, and report mpox promptly and effectively. We’ll also translate the most recent vaccine recommendations into practical workflows during Pride Season and in preparation for summer travel and events.
Presenters
Eric Tang, MD, MPH Public Health Medical Officer Office of Sexually Transmitted Infections (STIs) and Hepatitis C Virus (HCV) California Department of Public Health (CDPH) Clinical Faculty, California Prevention Training Center at UCSF
Jason Zucker, MD, MS Assistant Professor of Medicine Columbia University Irving Medical Center PI/Co-Medical Director NYC STI/HIV Prevention Training Center
Learning Objectives
Describe the latest epidemiological trends and key developments in mpox, both in the US and globally, with a particular focus on the emergence and clinical implications of clade I mpox
Identify and diagnose mpox and when to suspect clade I mpox, ensuring prompt and effective management
Integrate the most recent CDPH mpox vaccine and prevention recommendations into routine clinical practice
CAPTC is pleased to announce two job aids, focused on mpox recognition, diagnosis, testing, treatment, and vaccination.
The shorter job aid is called “Mpox Clinical Recognition and Testing Quicksheet: Mpox Presentations vs. Common Exanthems.” It is intended as a print resource, to help facilitate clinical recognition of mpox in health care settings. The longer job aid, “Mpox Clinical Recognition and Testing Overview,” is intended as an electronic resource. It has links to a number of helpful mpox-related resources.
The goal of this training is to prepare staff of local health departments to perform effective disease intervention (DI) interviews for mpox. This training aims to build on disease intervention skills by applying knowledge of the complexities and nuances specifically related to mpox DI interviews.
Learning Objectives By the end of these trainings, you should be able to:
Communicate accurate information about mpox symptoms, transmission, prevention, treatment, and services.
Gain awareness of the lived experiences of gay, bi, other men who have sex with men (MSM), including transgender men, and other trans people as it relates to mpox.
Understand a sex-positive, person-centered approach to taking a sexual history for mpox.
Use motivational interviewing and health coaching tools to support clients in seeking vaccination, screening, or treatment for mpox.
Examine personal and structural biases to reduce stigma during mpox interviews.
STI Clinical Update Webinar: California Mpox Update for Healthcare Providers – October 2023
Thursday, October 26, 2023 12:00 PM – 1:30 PM (PDT)
The California Department of Public Health (CDPH) continues to see statewide Mpox activity, including a large cluster in Los Angeles County. This webinar, presented by the California Prevention Training Center (CAPTC), features CDPH’s Mpox Clinical and Epidemiology teams, who will provide a clinical update and epidemiological overview of Mpox, and discuss new research findings relevant to primary care and other healthcare providers, including data on transmission, vaccine equity, and vaccine effectiveness. A question-and-answer session will follow.
Presented by:
Kayla Saadeh, MPH Mpox Epidemiology Unit Lead California Department of Public Health
Jessica Watson, MD, MPH Mpox Public Health Medical Officer and Acting Clinical Lead California Department of Public Health
Learning Objectives
Identify the clinical and epidemiological factors leading to Mpox infection, transmission, and severity as well as treatment options.
Apply the latest information and research on Mpox, including transmission characteristics, vaccine equity, and vaccine effectiveness, to your clinical practice to ensure patients are appropriately vaccinated, diagnosed, tested, and treated for Mpox.
Please note: CME not available for viewing the webinar recording.
STI Clinical Program Updates: Mpox letter and Bicillin shortage
The California Department of Public Health (CDPH) STD Control Branch has released two new important communications on: (1) Preventing a Resurgence of Mpox Cases in California and (2) Addressing an ongoing Bicillin® L-A shortage.
CDPH is aware that – while the rate of California (CA) mpox cases has declined precipitously since its peak in August 2022 – mpox transmission has continued in CA, and other states have recently reported a resurgence of mpox cases. Accordingly, CDPH has released a new Dear Colleague Letter intended as a call to action to Californian health care providers to remain vigilant in mpox prevention, recognition, and testing. This is especially important during the upcoming 2023 spring and summer season as people gather for festivals and events, including LGBTQ Pride Month in June. Information on how to diagnose, test for, and vaccinate against mpox is included.
(2) Health Advisory: Bicillin® L-A (Benzathine Penicillin G) Shortage
The Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) have announced a shortage of long-acting penicillin G benzathine injectable suspension products (Bicillin® L-A), with an estimated recovery timeframe not until Q4 of 2023. This is of considerable concern in CA, as the state continues to see significant increases in syphilis — including syphilis in pregnant persons and congenital syphilis in infants. CDPH has thus issued a Health Advisory addressing the Bicillin® L-A shortage, providing a framework for prioritization of limited Bicillin® L-A supplies when necessary, and recommending doxycycline as an alternative to Bicillin® L-A in appropriate clinical scenarios.
Sincerely,
California Prevention Training Center
Preventing Occupational Mpox Transmission in Outpatient Clinics
This resource includes practical tips for preventing mpox transmission in an outpatient setting, as implemented by many sexual health clinics during the current mpox outbreak. When space and resources are scarce or limited, implementing these real-world strategies allows clinics to care for patients with mpox as safely and effectively as possible.
STI Clinical Update Webinar-Back to Basics: Fundamentals of STI/HIV Prevention
Tuesday, March 28, 2023 from 12:00-1:15PM (PDT) A review of screening, treatment, and vaccination tools to prevent STIs and HIV. Presented by Drs. Caterina Liu and Kurtis Mohr
Learning Objectives:
Review screening and treatment guidance for STIs and HIV.
Integrate biochemical prevention tools for STIs and HIV into clinical practice.
Summarize recommendations for Hepatitis A, Hepatitis B, HPV, meningitis, and mpox vaccination.
STI Clinical Update Webinar: Syndromic Management of STIs – Part 2
Tuesday, December 6, 2022 from 12:00PM-1:15PM (PST)
Presented by Drs. Kathleen Jacobson and Kelly Johnson
A case-based approach to recognizing sexually transmitted infections, with a focus on those that disseminate outside the genital tract.
Learning Objectives
Identify various presentations of STI ulcerative disease
Understand that certain sexually transmitted infections (STIs) can disseminate outside the genital tract, sometimes causing severe disease
Recognize the varied clinical manifestations of disseminated STIs (including disseminated gonococcal infections, secondary syphilis, and mpox)
Understand how to diagnose and manage disseminated STIs
Mpox Frequently Asked Questions
Excellent FAQs and resources from Building Healthy Online Communities on the latest in mpox (formerly known as monkeypox) prevention, transmission, symptoms, and treatment. Updated regularly.
By clicking this box, you agree to use these videos for training and educational purposes only. Do not copy, download, share, or distribute the content. These materials may not be uploaded or used in artificial intelligence or machine learning systems.
We use cookies to ensure that we give you the best experience on our website, but we also recognize the right to privacy. Please accept or disable cookies for this website.
